Primary and Specialty HIV Care

• Purpose of This Guideline
• Goals of Primary Care for Adults With HIV
• History, Assessment, and Evaluation: Initial, Ongoing, and Annual
• Routine Screening and Primary Prevention
• Prevention of Opportunistic Infections
• Oral Health Complications
• All Recommendations

• Purpose of This Guidance
• Effects of Aging
• Approach to Aging in HIV Care
• Geriatric Screening and Assessment
• Integrating the Needs of Older Patients Into Medical Care

• Purpose of This Guideline
• Considerations and Contraindications
• COVID-19
• Haemophilus influenzae Type B (Hib)
• Hepatitis A Virus (HAV)
• Hepatitis B Virus (HBV)
• Human Papillomavirus (HPV)
• Influenza
• Measles, Mumps, Rubella (MMR)
• Meningococcal Serotypes A, C, W, and Y (MenACWY)
• Meningococcal Serotype B (MenB)
• Mpox
• Pneumococcal
• Tetanus, Diphtheria, and Pertussis (Tdap) and Tetanus-Diphtheria (Td)
• Varicella
• Zoster
• All Recommendations

• Introduction
• Linear Gingival Erythema (LGE)
• Necrotizing Ulcerative Gingivitis and Necrotizing Ulcerative Periodontitis (NUG/NUP)
• Necrotizing Ulcerative Stomatitis and Necrotizing Stomatitis (NUS/NS)
• Chronic Pre-Existing Periodontal Disease
• Appendix: Photo- and Radiographs of Periodontal Disease Associated With HIV
• All Recommendations

• Purpose of This Guideline
• HIV-Specific Perioperative Considerations
• All Recommendations

• Purpose of This Guideline
• Definition of Terms
• Goals of Screening and Risk Assessment
• Substance Use Screening for All Adult Patients in the Primary Care Setting
• Screening Tools
• Risk Assessment
• Management of Low-, Moderate-, and High-Risk Substance Use
• Diagnosis of Substance Use Disorder
• All Recommendations

• Purpose of This Guideline
• Rationale
• Who to Test for HCV Infection
• HCV Testing Sequence and Diagnosis
• All Recommendations

• Purpose of This Guideline
• HPV-Related Anal Disease in Individuals With HIV
• HPV Prevention
• Screening for Anal Disease
• Follow-Up of Abnormal Anal Cytology Results
• Treatment and Follow-Up
• All Recommendations

• Purpose of This Guideline
• HPV-Associated Cervical Disease
• HPV Prevention
• Cervical Cancer Prevention
• Screening for Cervical Abnormalities
• Screening for Cervical Dysplasia During Pregnancy
• Follow-Up of Abnormal Cervical Cytology Results
• Management of Cervical Cancer
• All Recommendations

• Purpose of This Guideline
• HPV-Associated Cancers
• HPV Prevention
• Cervical and Anal Cancer Screening
• Presentation and Diagnosis of HPV Infection
• HPV Treatment
• Partner Exposure to HIV and HPV
• All Recommendations

• Purpose of This Guidance
• Multifaceted Patient-Centered Sexual Health Care
• Components of a Patient-Centered Approach
• Resources for Care Providers

• What is U=U?
• Application to Clinical Practice
• Counseling Individuals About U=U
• Counseling Couples About U=U

For guidance on healthcare for transgender and non-binary individuals, please consult the World Professional Association for Transgender Health (WPATH) Standards of Care Version 8 and/or the University of California San Francisco (UCSF) Center of Excellence for Transgender Health Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People.

• Purpose of This Guidance
• New York State and Federal Law
• Disclosure, Consent, and Confidentiality
• Good Practice Reminders and Resources

• Clinical Guidelines Program Approach to Shared Decision-Making
• NYSDOH HIV Care Provider Definitions
• June 2016 Policy Statement: Defining Program Eligibility by HIV Status
• Meningococcal Disease: NYSDOH Health Advisory and Vaccine Recommendations
• Mental Health Screening Tools
• NYSDOH Health Equity Competencies for Health Care Providers
• Selected Links: Resources for Clinicians
• Selected Links: Resources for Consumers
• All FDA-Approved HIV Medications, With Brand Names and Abbreviations